InnoCare Optoelectronics (6861) Q2 2026 earnings summary

Executive summary

• Revenue for Q2 115 was NT$757,027K, up 37% year-over-year; net income for the quarter was NT$96,745K, up 202% year-over-year.

• For the first half of 115, revenue reached NT$1,548,068K, a 42% increase year-over-year; net income was NT$184,757K, up 147% year-over-year.

• Gross margin for Q2 115 was 29%, consistent with the prior year.

Financial highlights

• Operating income for Q2 115 was NT$95,076K, up 96% year-over-year; for H1 115, operating income was NT$182,891K, up 147%.

• Basic EPS for Q2 115 was NT$2.33, up from NT$0.77 in Q2 114; H1 115 EPS was NT$4.44, up from NT$1.80.

• Cash and equivalents at June 30, 115 were NT$867,461K.

• Inventory increased to NT$996,124K at June 30, 115, up from NT$503,487K a year earlier.

Outlook and guidance

• The company continues to focus on X-ray flat panel sensor medical business as its core segment.

• No early adoption of IFRS 18 and related amendments is planned; ongoing evaluation of new standards' impact.